Conjugated linoleic acid supplementation in humans--metabolic effects - PubMed (original) (raw)

Clinical Trial

Conjugated linoleic acid supplementation in humans--metabolic effects

A Smedman et al. Lipids. 2001 Aug.

Abstract

Supplementation with conjugated linoleic acid (CLA) induces a number of physiological effects in experimental animals, including reduced body fat content, decreased aortic lipid deposition, and improved serum lipid profile. Controlled trials on the effects of CLA in humans have hitherto been scarce. The aim of this study was to evaluate the effects of supplementation with CLA in healthy humans on anthropometric and metabolic variables and on the fatty acid composition of serum lipids and thrombocytes. Fifty-three healthy men and women, aged 23-63 yr, were randomly assigned to supplementation with CLA (4.2 g/d) or the same amount of olive oil during 12 wk in a double-blind fashion. The proportion of body fat decreased (-3.8%, P< 0.001) in the CLA-treated group, with a significant difference from the control group (P = 0.050). Body weight, body mass index, and sagittal abdominal diameter were unchanged. There were no major differences between the groups in serum lipoproteins, nonesterified fatty acids, plasma insulin, blood glucose, or plasminogen activator inhibitor 1 (PAI-1). In the CLA group the proportions of stearic, docosatetraenoic, and docosapentaenoic acids increased in serum lipids and thrombocytes, while proportions of palmitic, oleic, and dihomo-gamma-linolenic acids decreased, causing a decrease of the estimated delta-6 and delta-9 and an increase in the delta-5 desaturase activities. These results suggest that supplementation with CLA may reduce the proportion of body fat in humans and that CLA affects fatty acid metabolism. No effects on body weight, serum lipids, glucose metabolism, or PAI-1 were seen.

PubMed Disclaimer

Cited by

Evaluation of Downstream Processing, Extraction, and Quantification Strategies for Single Cell Oil Produced by the Oleaginous Yeasts Saitozyma podzolica DSM 27192 and Apiotrichum porosum DSM 27194.
Gorte O, Hollenbach R, Papachristou I, Steinweg C, Silve A, Frey W, Syldatk C, Ochsenreither K. Gorte O, et al. Front Bioeng Biotechnol. 2020 Apr 24;8:355. doi: 10.3389/fbioe.2020.00355. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32391350 Free PMC article.
CLA and body weight regulation in humans.
Risérus U, Smedman A, Basu S, Vessby B. Risérus U, et al. Lipids. 2003 Feb;38(2):133-7. doi: 10.1007/s11745-003-1043-7. Lipids. 2003. PMID: 12733745 Review.
A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef.
Daley CA, Abbott A, Doyle PS, Nader GA, Larson S. Daley CA, et al. Nutr J. 2010 Mar 10;9:10. doi: 10.1186/1475-2891-9-10. Nutr J. 2010. PMID: 20219103 Free PMC article. Review.
The diversity of health effects of individual trans fatty acid isomers.
Gebauer SK, Psota TL, Kris-Etherton PM. Gebauer SK, et al. Lipids. 2007 Sep;42(9):787-99. doi: 10.1007/s11745-007-3095-8. Epub 2007 Aug 11. Lipids. 2007. PMID: 17694343 Review.
Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks.
Kelley DS, Erickson KL. Kelley DS, et al. Lipids. 2003 Apr;38(4):377-86. doi: 10.1007/s11745-003-1072-2. Lipids. 2003. PMID: 12848282 Review.

References

1. J Nutr. 2000 Jan;130(1):27-9 - PubMed
1. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):1-6 - PubMed
1. Br J Nutr. 1999 Oct;82(4):309-17 - PubMed
1. Prog Lipid Res. 2001 Jul;40(4):283-98 - PubMed
1. Am J Clin Nutr. 1998 Feb;67(2):332-7 - PubMed

Conjugated linoleic acid supplementation in humans--metabolic effects - PubMed (original) (raw)